Aripiprazole LAI two‐injection start in a 16 year‐old adolescent with schizophrenia

BACKGROUND: Aripiprazole long‐acting injection (LAI) is approved for the treatment of schizophrenia in adults. Recently, Europe and Canada approved the use of the two‐injection start regimen: two separate injections of 400‐mg long‐acting aripiprazole along with a single 20‐mg dose of oral aripiprazo...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvi, Virginio, Appignanesi, Cristina, Marpepa, Brodinela, Orsolini, Laura, Volpe, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216357/
https://www.ncbi.nlm.nih.gov/pubmed/35182040
http://dx.doi.org/10.1002/npr2.12240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216357/
https://www.ncbi.nlm.nih.gov/pubmed/35182040
http://dx.doi.org/10.1002/npr2.12240

Ejemplares similares